The Tough Tech problem we are solving
Oxbridge Clinical is addressing the global challenge that, although clinicians can often recognize an infection, they lack practical tools at the point of care to identify the specific microorganism and its antibiotic resistance profile quickly and affordably. This gap leads to widespread use of broad‑spectrum antibiotics, driving antimicrobial resistance toward becoming a leading cause of death while patients continue to face avoidable hospitalizations and delayed, often inappropriate, treatment.
About our solution
Oxbridge Clinical is developing an ultra‑low‑cost, pocket‑sized diagnostic platform that provides germ‑specific, quantitative analysis of bacteria, viruses, and fungi directly from raw samples in minutes, without a lab, molecular reagents, or complex infrastructure. By combining solid‑state micropore sensing with a state‑of‑the‑art AI engine, the system is designed to deliver lab‑grade accuracy, rapid antibiograms, and per‑test costs far below PCR, enabling one versatile test that can be deployed in clinics, at the bedside, and on the factory floor for both clinical and non‑clinical applications.